| Trial ID: | L0030 |
| Source ID: | NCT00677521
|
| Associated Drug: |
Acarbose
|
| Title: |
A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)
|
| Acronym: |
--
|
| Status: |
Terminated
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Acarbose
|
| Outcome Measures: |
Improvement of hepatic steatosis as measured by proton magnetic resonance spectroscopy|Postprandial substrate metabolism reflected in the respiratory quotient (RQ) measured by indirect calorimetry
|
| Sponsor/Collaborators: |
The Hospital for Sick Children
|
| Gender: |
All
|
| Age: |
10 Years to 18 Years ?? (Child, Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
1
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
January 2007
|
| Completion Date: |
August 2008
|
| Results First Posted: |
--
|
| Last Update Posted: |
August 19, 2013
|
| Locations: |
The Hospital for Sick Children, Toronto, Ontario, Canada
|
| URL: |
https://ClinicalTrials.gov/show/NCT00677521
|
